DV Biomed Co., Ltd. (TPEX:6539)
Taiwan · Delayed Price · Currency is TWD 35.80
-1.55 (-4.15%)
Oct 20, 2026, 11:14 AM CST
DV Biomed Market Cap
DV Biomed has a market cap or net worth of 871.69 million as of October 20, 2026. It is the 34,837th most valuable company in the world and the 2,105th biggest in Taiwan. Its market cap has decreased by 36.64% in one year.
Market Cap
871.69M
Enterprise Value
555.79M
Revenue
795.19M
Global Rank
Country Rank
#2,105 Taiwan
PE Ratio
11.33
ChartMarket Cap Chart
Since October 15, 2015, DV Biomed's market cap has decreased from 5.01B to 871.69M, a decrease of -82.59%. That is a compound annual growth rate of -14.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 871.69M | -39.32% |
| Dec 31, 2025 | 1.44B | 11.93% |
| Dec 30, 2024 | 1.28B | -55.96% |
| Dec 29, 2023 | 2.91B | -11.33% |
| Dec 30, 2022 | 3.29B | -5.52% |
| Dec 30, 2021 | 3.48B | -17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tien Liang BioTech | 1.75B |
| InnoPharmax | 1.19B |
| GeneFerm Biotechnology | 1.19B |
| Excelsior Biopharma | 1.07B |
| Prince Pharmaceutical | 1.07B |
| Anxo Pharmaceutical | 1.06B |
| Original BioMedicals | 801.70M |
| Mediera | 796.39M |